| ²é¿´: 836 | »Ø¸´: 5 | |||
[½»Á÷]
ÄϾ©´«ÆæÉúÎïÕÐÆ¸ ÌåÄÚҩЧ¸ß¼¶¿ÆÑ§¼Ò
|
|||
|
???????¡ì???????¡ì?? Senior Scientist of in-vivo Pharmacology Nanjing, China Key Responsibilities: 1. Develop appropriate in-vivo functional assays based on the knowledge of mechanisms of drug action and assay development principles in Biologics discovery and development. 2. Possess/ gain a thorough understanding of regulatory guidelines of in-vivo assay development and analysis. 3. Manage in-vivo assay projects and communicate with vendors to ensure the success of projects. Qualifications: 1. Ph. D in immunology, biomedical sciences, cell biology, biochemistry or related field. 2. With over 5 years of hands-on experience in developing in-vivo bioassays, pharmacodynamics studies and developbility evaluation of Ab drug candidates. 3. Knowledge of in-vivo assay development principles and regulatory guidance for Ab drug discovery and development. 4. Experience in drug targets evaluation , in-vivo functional assays development and immune check point assays is highly desired. [ ??¡Á?¡ã??¨¦?? ???? ] |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
293µ÷¼Á
ÒѾÓÐ3È˻ظ´
»úе¹¤³Ì264ѧ˶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
264Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
22408 266Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ43È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
338Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ºþ±±´óѧ ¿óÎï¼°¹Ì·Ï×ÊÔ´»¯ÀûÓû·¾³ÄÜԴвÄÁÏÑо¿ÍÅ¶Ó ²ÄÁÏÓ뻯¹¤ µ÷¼ÁÕÐÉú
+2/462
ÉúÎïÓëҽҩרҵ˶ʿµ÷¼Á£¨ºÓ±±´óѧ »¯Ñ§Óë²ÄÁÏ¿ÆÑ§Ñ§Ôº£©
+2/90
ÐèÒªµ÷¼Á»¯Ñ§×¨ÒµµÄ¿´¹ýÀ´
+1/40
Ìì½ò¿Æ´óÇṤѧԺ¹ú¼Ò¼¶È˲ÅÍŶÓÕÐÊÕ»¯Ñ§¡¢²ÄÁÏ¡¢Ê³Æ·µ÷¼Á
+1/36
ÉϺ£Ó¦Óü¼Êõ´óѧҦ×Ó½¨¿ÎÌâ×éÕÐÉú£¬µã»÷¾ÍËÍÑо¿ÉúѧÀú
+1/26
ÉϺ£Ó¦Óü¼Êõ´óѧҦ×Ó½¨¿ÎÌâ×éÕÐÉú£¬´óѧipÉϺ££¬µã»÷¾ÍËÍÑо¿ÉúѧÀú
+1/25
½ËÕº£Ñó´óѧ+»·¾³Ó뻯ѧ¹¤³ÌѧԺ+¿ÎÌâ×éÕе÷¼ÁÉú+µÚÒ»Åúµ÷¼Á
+2/22
Õã½áéÖÝ£¬áéÖÝѧԺ»¯Ñ§Óë²ÄÁϹ¤³ÌѧԺÕÐÊÕÈ«Ìå08¡¢²¿·Ö07¡¢09µ÷¼Áͬѧ
+1/21
¡¾²©Ê¿ÕÐÉú¡¿Î人¿Æ¼¼´óѧÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀà2026Äê¡°ÉêÇë-¿¼ºË¡±ÖƲ©Ê¿Éú
+1/12
ÕÐ˶ʿÑо¿Éú£¡ÕÐ˶ʿÑо¿Éú£¡ÕÐ˶ʿÑо¿Éú£¡ÕÐÉúרҵ£º»¯Ñ§
+1/11
ÇóÍÆ¼ö»¯Ñ§²ÄÁÏÀàºÃͶ¡¢¼û¿¯¿ìµÄÆÚ¿¯
+1/11
¼ªÁÖ¹¤³Ì¼¼Êõʦ·¶Ñ§Ôº¿¼Ñе÷¼ÁÕÐÉúÐÅÏ¢
+3/10
º£ÄÏ´óѧ2026Ñо¿Éúµ÷¼Á-º£Ñó¿ÆÑ§Àà¡¢µØÖÊÀà¡¢·ÖÎö»¯Ñ§¡¢»·¾³Àà¡¢Éú̬ѧ/ÉúÎïѧ
+1/7
ºÓÄÏÀí¹¤´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÐÊÕ²ÄÁÏ¡¢»¯¹¤Ààרҵµ÷¼ÁÑо¿Éú
+1/7
¸£½¨Å©ÁÖ´óÑ§ÇØÔ´¿ÎÌâ×éÕÐÊÕ2026Äê ÉúÎïѧ¡¢ÉúÎï¼¼ÊõÓ빤³ÌרҵÑо¿ÉúÈô¸ÉÃû
+1/6
ÀöˮѧԺ²ÄÄÜѧԺ-ÏȽøÄÜÔ´´æ´¢ÓëÆ÷¼þ¿ÎÌâ×é-26½ìÑо¿ÉúÕÐÉú-£¨ÐÂÄÜÔ´µç³Ø·½Ïò£©
+1/5
0854,0858µ÷¼ÁÕÐÉú
+1/3
Ò»Ö¾Ô¸211µç×ÓÐÅÏ¢347Çóµ÷¼Á
+1/3
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
+1/2
ɽ¶«Ä³Ë«Ò»Á÷ԺУ0857ÕÐÊÕµ÷¼Á
+1/1
¼òµ¥»Ø¸´
159413916672Â¥
2019-03-05 13:29
»Ø¸´
½ð˹Èð1226(½ð±Ò+1): лл²ÎÓë
star199111283Â¥
2019-03-05 13:38
»Ø¸´
½ð˹Èð1226(½ð±Ò+1): лл²ÎÓë
ºÃ ·¢×ÔСľ³æIOS¿Í»§¶Ë
syhorchid4Â¥
2019-03-05 13:38
»Ø¸´
½ð˹Èð1226(½ð±Ò+1): лл²ÎÓë
student_yy5Â¥
2019-03-05 13:40
»Ø¸´
½ð˹Èð1226(½ð±Ò+1): лл²ÎÓë
òßòÑÈýÖ»6Â¥
2019-03-05 13:48
»Ø¸´
½ð˹Èð1226(½ð±Ò+1): лл²ÎÓë
H ·¢×ÔСľ³æAndroid¿Í»§¶Ë














»Ø¸´´ËÂ¥